Skip to main content
SpringerLink
Log in

Parvovirus B19 diagnosis in pregnant women — quantification of IgG antibody levels (IU/ml) with reference to the international parvovirus B19 standard serum

  • Brief Report
  • Published:
Infection Aims and scope Submit manuscript

Summary

On the basis of the results of a collaborative study the Expert Committee on Biological Standardisation of the World Health Organisation has issued an international standard (IS) serum for parvovirus B19 IgG antibody (NIBSC 93/724). In this study this IS was used to calibrate an in-house standard serum for reporting the results of parvovirus B19 IgG testing in IU/ml. The IgG titre distribution in 939 pregnant women was determined. These samples were sent to the laboratory for determining the immune status to parvovirus B19 following contact with parvovirus B19 infected individuals or for detecting acute infection in patients with symptoms suggestive of parvovirus B19 infection.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Cohen, B. Parvovirus B19: an expanding spectrum of disease. Br. Med. J. 311 (1995) 1549–1552.

    Google Scholar 

  2. Public Health Laboratory Service Working Party of Fifth Disease Prospective study of human parvovirus (B19) infection in pregnancy. Br. Med. J. 300 (1990) 1166–1170.

    Google Scholar 

  3. Schwarz, T. F., Nerlich, A., Roggendorf, H., Hottenträger, B., Jäger, G., Schramm, T., Gloning, K. P., Roggendorf, M. Parvovirus B19 infection in pregnancy. Int. J. Exp. Clin. Chemother. 3 (1990) 219–223.

    Google Scholar 

  4. Ferguson, M., Walker, D., Cohen, B.: Report of a collaborative study to assess the suitability of the proposed international standard for parvovirus B19 serum IgG. Biologicals, in press.

  5. Bansal, G. P., Hatfield, J. A., Dunn, F. E., Kramer, A. A., Brady, F., Riggin, C. H., Collett, M. S., Yoshimoto, K., Kajigaya, S., Young, N. S. Candidate recombinant vaccine for human B19 parvovirus. J. Infect. Dis. 167 (1993) 1034–1044.

    PubMed  Google Scholar 

  6. Enders, G.: Infections of the fetus and neonate other than rubella. In:Collier, L. (ed.): Topley & Wilson's Microbiology and Microbial Infections, 9th ed. Edward Arnold, London, in press.

Download references

Author information

Authors and Affiliations

  1. Medizinisch-Diagnostisches Gemeinschaftslabor Prof. Enders und Kollegen und Institut für Virologie, Infektiologie und Epidemiologie, Rosenbergstr. 85, D-70193, Stuttgart, Germany

    Karen Searle Ph. D., Carola Guilliard (MTA) &  Gisela Enders

Authors
  1. Karen Searle Ph. D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Carola Guilliard
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Gisela Enders
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Searle, K., Guilliard, C. & Enders, G. Parvovirus B19 diagnosis in pregnant women — quantification of IgG antibody levels (IU/ml) with reference to the international parvovirus B19 standard serum. Infection 25, 32–34 (1997). https://doi.org/10.1007/BF02113504

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02113504

Keywords

Search

Navigation